Link to this page
Physician Data Query
Last uploaded:
August 27, 2019
Jump to:
| Id | http://purl.bioontology.org/ontology/PDQ/CDR0000038289
http://purl.bioontology.org/ontology/PDQ/CDR0000038289
|
|---|---|
| Preferred Name | valganciclovir |
| Definitions |
A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2629" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2629" NCI Thesaurus)
|
| Synonyms |
VGCV
Valcyte
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2629" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2629" NCI Thesaurus) |
|---|---|
| altLabel |
VGCV
Valcyte
|
| prefLabel | valganciclovir
|
| notation | CDR0000038289
|
| ORIG STY | Drug/agent
|
| Component of | |
| Legacy PDQ ID | 10899
|
| Date last modified | 2006-09-28
|
| Semantic type UMLS property | |
| NCI ID | C2629
|
| type | |
| LT | TRD
|
| tui |
T109
T121
|
| cui |
C0969586
C0909381
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |